I-25% ye-Tilmicosin Oral Solution yenkukhu
.png)
.png)
.png)
.png)
Ukuqamba
I-100ml iqulethe i-25g ye-Tilmicosin.
Isenzo se-Pharmacological
I-Pharmacodynamics Teicoplanin sisibulali-zintsholongwane semisynthetic macrolide esinikezelwe kwizilwanyana.Kwi-mycoplasma, impembelelo ye-antibacterial iyafana ne-tylosin, kwaye iibhaktheriya ezithintekayo zegram yi-Staphylococcus aureus (kubandakanya i-penicillin-resistant Staphylococcus aureus), i-pneumococcus, i-streptococcus, i-Bacillus anthracis, i-Erysipelothrix, i-Portos, i-Listtores, i-Listtores, i-Portugus, i-Portuguese, i-Erysipelothrix, i-Portuguese, i-Pneumococcus. emphysematosus.Iibhaktheriya ezibuthathaka kwigram-negative ziquka i-Haemophilus, i-meningococcus kunye ne-Pasteurella.Isebenza ngakumbi kune-tylosin ngokuchasene ne-Actinobacillus pleuropneumoniae, i-Pasteurella kunye ne-Mycoplasma bovis.Iipesenti ezingamashumi alithoba anesihlanu eepesenti zePasteurella haemolytica zichaphazeleka kule mveliso.
Pharmacokinetics
Isisombululo se-Tilmicosin sithatyathwa ngokukhawuleza emva kokulawulwa komlomo kwaye sibonakaliswe ngokungena kwezicubu ezinamandla kunye nomthamo omkhulu wokusabalalisa (ubukhulu kune-2 L / kg).Ukugxininiswa kwimiphunga kuphezulu, ukupheliswa kobomi besiqingatha kunokufikelela kwi-1 ukuya kwiintsuku ze-2, kwaye i-concentration ye-plasma esebenzayo igcinwa ixesha elide.
Ukusebenzisana kweziyobisi
(1) I-Tilmicosin inenjongo efanayo njengamanye ama-macrolides kunye ne-lincosamines kwaye akufanele isetyenziswe ngexesha elifanayo.
(2) indibaniselwano kunye ne-β-lactam ibonise ukuchasana.
Ixesha lokurhoxisa
Iintsuku ezingama-27 ngaphambi kokuxhela.
Ayinakusetyenziswa kwiinkomo zobisi ezineminyaka yobudala, okanye nakweyiphi na inkomo ngexesha lokuqala leentsuku ezingama-45 zokukhulelwa (okanye iintsuku zokuqala ezingama-45 emva kokususa inkunzi)
Isenzo kunye nokusetyenziswa
Macrolide antibiotics.Isetyenziselwa ukunyanga izifo zenkukhu ezibangelwa yi-Pasteurella kunye ne-Mycoplasma.
Umthamo kunye nolawulo
Isiselo esixutywe: 0.3 ml nge-1 L yamanzi kwiinkukhu.Kwiintsuku ezi-3.
Ukusabela kakubi
Impembelelo eyityhefu yale mveliso kwizilwanyana ikakhulu yinkqubo ye-cardiovascular system, enokubangela i-tachycardia kunye ne-contractility ebuthathaka.
Ukulumkela
Isisombululo somlomo we-Tilmicosin sichasana ekubekeni iinkukhu ngexesha lokubeka.
Ixesha lokurhoxisa
Iinkukhu iintsuku ezili-12.
Ugcino
Gcina kwindawo evaliweyo, ukhuselwe ekukhanyeni.
I-Hebei Veyong Pharmaceutical Co., Ltd, yasekwa kwi-2002, ehlala kwisiXeko saseShijiazhuang, kwiPhondo laseHebei, eChina, ecaleni kwe-Capital Beijing.Ulishishini elikhulu leyeza lezilwanyana eliqinisekisiweyo le-GMP, eline-R&D, imveliso kunye nokuthengiswa kwee-APIs zonyango lwezilwanyana, amalungiselelo, ukutya okuxutywe kwangaphambili kunye nezongezo zokutya.NjengeZiko lobuGcisa lePhondo, iVeyong iye yaseka inkqubo yeR&D ehlaziyiweyo yeyeza elitsha lezilwanyana, kwaye lishishini elaziwa kuzwelonke leteknoloji esekelwe kunyango lwezilwanyana, kukho iingcali zobugcisa ezingama-65.I-Veyong ineziseko ezimbini zokuvelisa: i-Shijiazhuang kunye ne-Ordos, apho isiseko se-Shijiazhuang sihlanganisa indawo ye-78,706 m2, kunye neemveliso ze-API ze-13 ezibandakanya i-Ivermectin, i-Eprinomectin, i-Tiamulin Fumarate, i-Oxytetracycline hydrochloride ects, kunye ne-11, i-injection oral solutions, i-injection oral solutions. , i-premix, i-bolus, i-pesticides kunye ne-disinfectant, njl.IVeyong ibonelela ngee-APIs, ngaphezulu kwe-100 yamalungiselelo eleyibhile, kunye nenkonzo ye-OEM & ODM.
I-Veyong ibona ukubaluleka okukhulu kulawulo lwenkqubo ye-EHS(Environment, Health & Safety), kwaye ifumene i-ISO14001 kunye nezatifikethi ze-OHSAS18001.I-Veyong idweliswe kumashishini amashishini asakhasayo anobuchule kwiPhondo laseHebei kwaye inokuqinisekisa ukubonelela ngokuqhubekayo kweemveliso.
I-Veyong yaseka inkqubo epheleleyo yolawulo lomgangatho, yafumana isatifikethi se-ISO9001, isatifikethi se-GMP sase-China, isiqinisekiso se-APVMA se-GMP sase-Australia, isatifikethi se-GMP sase-Ethiopia, isatifikethi se-Ivermectin CEP, kwaye siphumelele ukuhlolwa kwe-US FDA.I-Veyong ineqela lobuchwephesha lobhaliso, intengiso kunye nenkonzo yobugcisa, inkampani yethu ifumene ukuthembela kunye nenkxaso kubathengi abaninzi ngomgangatho wemveliso ogqwesileyo, umgangatho ophezulu wokuthengisa kwangaphambili kunye nenkonzo yasemva kokuthengisa, ulawulo olunzulu kunye nolwenzululwazi.I-Veyong yenze intsebenziswano yexesha elide kunye namashishini amaninzi amachiza ezilwanyana awaziwayo ngamazwe ngamazwe kunye neemveliso ezithunyelwa eYurophu, eMzantsi Melika, kuMbindi Mpuma, e-Afrika, e-Asia, njl. ngaphezu kwamazwe angama-60 kunye nemimandla.
